Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 686Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7AXIM

02 2Farmak JSC

03 17GE Healthcare Inc

04 35GUERBET

05 6Hainan Poly Pharm

06 5Jiangsu Hengrui Medicine

07 5beimaging.ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : CLARISCAN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 3.769GM/10ML (376.9MG/ML)

Packaging :

Approval Date : 2019-11-01

Application Number : 210016

Regulatory Info : RX

Registration Country : USA

blank

02

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : CLARISCAN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5.6535GM/15ML (376.9MG/ML)

Packaging :

Approval Date : 2019-11-01

Application Number : 210016

Regulatory Info : RX

Registration Country : USA

blank

03

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : CLARISCAN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 7.538GM/20ML (376.9MG/ML)

Packaging :

Approval Date : 2019-11-01

Application Number : 210016

Regulatory Info : RX

Registration Country : USA

blank

04

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : CLARISCAN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 37.69GM/100ML (376.9MG/ML)

Packaging :

Approval Date : 2020-08-04

Application Number : 210016

Regulatory Info : RX

Registration Country : USA

blank

05

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : CLARISCAN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1.8845GM/5ML (376.9MG/ML)

Packaging :

Approval Date : 2020-11-24

Application Number : 210016

Regulatory Info : RX

Registration Country : USA

blank

06

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : DOTAREM

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 37.69GM/100ML (376.9MG/ML)

Packaging :

Approval Date : 2013-03-20

Application Number : 204781

Regulatory Info : RX

Registration Country : USA

blank

07

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : DOTAREM

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 3.769GM/10ML (376.9MG/ML)

Packaging :

Approval Date : 2013-03-20

Application Number : 204781

Regulatory Info : RX

Registration Country : USA

blank

08

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : DOTAREM

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5.6535GM/15ML (376.9MG/ML)

Packaging :

Approval Date : 2013-03-20

Application Number : 204781

Regulatory Info : RX

Registration Country : USA

blank

09

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : DOTAREM

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 7.538GM/20ML (376.9MG/ML)

Packaging :

Approval Date : 2013-03-20

Application Number : 204781

Regulatory Info : RX

Registration Country : USA

blank

10

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : DOTAREM

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1.8845GM/5ML (376.9MG/ML)

Packaging :

Approval Date : 2017-03-31

Application Number : 204781

Regulatory Info : RX

Registration Country : USA

blank

11

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1.8845GM/5ML (376.9MG/ML)

Packaging :

Approval Date : 2024-06-17

Application Number : 218073

Regulatory Info : RX

Registration Country : USA

blank

12

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 3.769GM/10ML (376.9MG/ML)

Packaging :

Approval Date : 2024-06-17

Application Number : 218073

Regulatory Info : RX

Registration Country : USA

blank

13

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5.6535GM/15ML (376.9MG/ML)

Packaging :

Approval Date : 2024-06-17

Application Number : 218073

Regulatory Info : RX

Registration Country : USA

blank

14

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 7.538GM/20ML (376.9MG/ML)

Packaging :

Approval Date : 2024-06-17

Application Number : 218073

Regulatory Info : RX

Registration Country : USA

blank

15

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 37.69GM/100ML (376.9MG/ML)

Packaging :

Approval Date : 2024-06-17

Application Number : 218073

Regulatory Info : RX

Registration Country : USA

blank

16

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1.8845GM/5ML (376.9MG/ML)

Packaging :

Approval Date : 2022-04-11

Application Number : 215304

Regulatory Info : RX

Registration Country : USA

blank

17

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 3.769GM/10ML (376.9MG/ML)

Packaging :

Approval Date : 2022-04-11

Application Number : 215304

Regulatory Info : RX

Registration Country : USA

blank

18

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 5.6535GM/15ML (376.9MG/ML)

Packaging :

Approval Date : 2022-04-11

Application Number : 215304

Regulatory Info : RX

Registration Country : USA

blank

19

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 7.538GM/20ML (376.9MG/ML)

Packaging :

Approval Date : 2022-04-11

Application Number : 215304

Regulatory Info : RX

Registration Country : USA

blank

20

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

GADOTERATE MEGLUMINE

Brand Name : GADOTERATE MEGLUMINE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 37.69GM/100ML (376.9MG/ML)

Packaging :

Approval Date : 2022-04-15

Application Number : 215304

Regulatory Info : RX

Registration Country : USA

blank